Hypofractionated Boost Before Chemoradiation for Patients With Stage II-III Non-small Cell Lung Cancer Unsuitable for Surgery

NCT02262325 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Non-small Cell Lung Cancer
Stage IIA Non-small Cell Lung Cancer
Stage IIB Non-small Cell Lung Cancer
Stage IIIA Non-small Cell Lung Cancer
Stage IIIB Non-small Cell Lung Cancer

Interventions

RADIATION: hypofractionated radiation therapy
DRUG: cisplatin
DRUG: etoposide
RADIATION: 3-dimensional conformal radiation therapy
OTHER: laboratory biomarker analysis

Sponsor

Ohio State University Comprehensive Cancer Center